Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
BRIEF-Nykode Therapeutics Receives U.S. Vaccine Patent Aug 20 (Reuters) - Nykode Therapeutics ASA NYKD.OL:
RECEIVES NEW U.S. PATENT
USPTO ISSUES U.S. PATENT COVERING NYKODE'S VB10.NEO AND RELATED DNA VACCINE DESIGNS
Source text: ID:nObiTyJsYa
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026